학술논문
Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc Analysis From the Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial (IDNT)
Document Type
Article
Author
Source
In American Journal of Kidney Diseases February 2014 63(2):244-250
Subject
Language
ISSN
0272-6386